AIMLF (AI/ML Innovations) Ending Cash Position: $0.31 Mil (As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is AI/ML Innovations Ending Cash Position?

AI/ML Innovations AIMLF +7.86% Ending Cash Position is $0.31 Mil as of Jan. 2026. The stock has 4 warning signs investors should review.

AI/ML Innovations's Ending Cash Position for the quarter that ended in Jan. 2026 was $0.31 Mil.

AI/ML Innovations's quarterly Ending Cash Position increased from Jul. 2025 ($0.78 Mil) to Oct. 2025 ($0.80 Mil) but then declined from Oct. 2025 ($0.80 Mil) to Jan. 2026 ($0.31 Mil).

AI/ML Innovations's annual Ending Cash Position increased from Apr. 2023 ($0.00 Mil) to Apr. 2024 ($0.15 Mil) and increased from Apr. 2024 ($0.15 Mil) to Apr. 2025 ($1.42 Mil).

AI/ML Innovations Ending Cash Position Related Terms

AI/ML Innovations Ending Cash Position Historical Data

* Premium members only.

The historical data trend for AI/ML Innovations's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AI/ML Innovations Ending Cash Position Chart

AI/ML Innovations Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.70 0.38 0.00 0.15 1.42

AI/ML Innovations Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.29 1.42 0.78 0.80 0.31

AI/ML Innovations Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

AI/ML Innovations's Ending Cash Position for the fiscal year that ended in Apr. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.144+1.28
=1.42

AI/ML Innovations's Ending Cash Position for the quarter that ended in Jan. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.813+-0.501
=0.31

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $0.31 Mil mean?
AI/ML Innovations (AIMLF) has a Ending Cash Position of $0.31 Mil as of Jan. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on AI/ML Innovations and its competitors.
Is AI/ML Innovations' Ending Cash Position too high?
AI/ML Innovations' current Ending Cash Position is $0.31 Mil.
How does AI/ML Innovations' Ending Cash Position compare to VEEV and BTSG?
AI/ML Innovations' Ending Cash Position of $0.31 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Healthcare Providers & Services company?
A good Ending Cash Position depends on the Healthcare Providers & Services industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on AI/ML Innovations and its competitors. AI/ML Innovations's current Ending Cash Position is $0.31 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AI/ML Innovations stock overvalued right now?
Based on GuruFocus' analysis, AI/ML Innovations (AIMLF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.01, compared to a current price of $0.03 — trading 243% above its estimated fair value. The current Ending Cash Position is $0.31 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For AI/ML Innovations (AIMLF), the current Ending Cash Position is $0.31 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AI/ML Innovations Business Description

Other Exchanges 42F:GermanyAIML:Canada
Address 645 Fort Street, Suite 203, Victoria, BC, CAN, V8W 1G2
AI/ML Innovations Inc is a holding company. The company along with its subsidiaries is engaged in the research and development of health and wearable technologies, and the sale of licenses and consulting services related to those technologies.